Mylan, Inc. (MYL) Misses Q2 EPS by 4c; Trims FY14 Outlook
Get Alerts MYL Hot Sheet
Price: $15.86 --0%
Financial Fact:
Selling, general and administrative: 425.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 425.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Mylan, Inc. (NASDAQ: MYL) reported Q2 EPS of $0.69, $0.04 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.88 billion.
Mylan, Inc. sees FY2014 EPS of $3.25-$3.45, versus prior guidance of $3.25-$3.6 and the consensus of $3.37. Mylan, Inc. sees FY2014 revenue of $7.8-8.0 billion, versus prior guidance of $7.8-8.2 billion and the consensus of $7.77 billion.
For earnings history and earnings-related data on Mylan, Inc. (MYL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share